CTRI/2016/08/007176
Completed
未知
Prospective, randomized, double blind, placebo controlled, clinical study to compare different doses of ketamine for prevention of shivering during spinal anaesthesia
okmanya Tilak Muncipal Medical College and General Hospital0 sites120 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- okmanya Tilak Muncipal Medical College and General Hospital
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •ASA I \& II , Height 150\-170cms
Exclusion Criteria
- •1\)Patient unwilling for consent
- •2\) Patient with Thyroid disorder
- •3\) Patient with severe cardiopulmonary disease
- •4\) Patient requiring transfusion of blood and blood products
- •5\)Endoscopic urological procedures
- •6\)Pregnancy
- •7\)BMI \>30 kg/m2
- •8\)Contraindication for central neuraxial blockade
- •9\) Coaugulopathy , H/O any allergy to local anaesthetic
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Prospective, double-blind, randomised, placebo controlled, phase III clinical study assessing the efficacy of natural progesterone 25 mg/bid administered subcutaneously in the maintenance of early pregnancy in women with symptoms of threatened abortion.EUCTR2016-002777-35-ITIBSA INSTITUT BIOCHIMIQUE SA268
Active, not recruiting
Phase 1
Prospective, randomised, double-blind, placebo controlled, phase III clinical study assessing the efficacy of 25 mg natural progesterone administered subcutaneously in restoring the normal luteal phase in women with previous diagnosis of luteal phase deficiency.EUCTR2016-002731-14-ITIBSA INSTITUT BIOCHIMIQUE SA60
Recruiting
Not Applicable
Effectiveness of lithium microdose in the treatment of Alzheimer's disease.Alzheimer's diseaseC10.228.140.380.100RBR-6cf6rpFaculdade de Ciências Médicas da Santa Casa de São Paulo
Active, not recruiting
Phase 1
Prospective, double-blind, randomized, placebo-controlled dose finding study of the efficacy and safety of 2 target doses of Org 34517 used as adjunctive therapy in subjects with psychotic major depression (major depressive episode, severe, with psychotic features)Psychotic major depression (major depressive episode, severe, with psychotic features)MedDRA version: 6.1 Level: LLT Classification code 10037250EUCTR2004-000050-23-CZV Organon300
Active, not recruiting
Not Applicable
Prospective, double-blind, randomized, placebo-controlled, parallel group, multi-centre phase III study to evaluate the efficacy and safety of a human leukocytic ultrafiltrate (Leukonorm Cytochemia®) applied as supportive immunotherapy within IVF/ICSI-treatment in female patients with repetitive implantation failures during previous IVF or ICSI-cycles - CYCLEfemale patients with repetitive implantation failures during previous IVF/ICSI-cyclesEUCTR2006-000014-20-DECYTOCHEMIA AG208